References
- Klastersky J. Empiric treatment of infections in neutropenic patients with cancer. Rev Infect Dis 1983; 5: S21–31
- Sculier JP, Weerts D, Klastersky J. Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapy. Eur J Cancer Clin Oncol 1984; 20: 55–60
- Brown AE. eutropenia, fever and infection. Am J Med 1984; 76: 421–428, N
- Pizzo PA, Hathorn JW, Hiemenz J, Browne M, Commers J, Cotton D, Gress J, Thaler M, Wesley R. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986; 315: 552
- Rolston K VI, Leblanc B, Ho DH. In vitro activity of RU 28965, a new macrolide, compared to that of erythromycin. J Antimicrob Chemother 1986; 17: 161–163
- Jawetz E, Melnick JL, Adelberg EA. Review of medical microbiology. Lange, California 1982; 117–145
- Hoogeterp JJ. Efficacy of antibiotics against Staphylococcus aureus: kinetic and dynamic studies in normal and granulocytopenic mice. Leiden 1988, PhD Thesis
- Calame W, van der Waals R, Mattie H, van Furth R. Influence of etoposide and cyclophosphamide on the efficacy of cloxacillin and erythromycin in an experimental staphylococcal infection. Antimicrob Agents Chemother 1989; 33: 980–982
- Jones RN, Barry AL, Thornsberry C. In vitro evaluation of three new macrolide antimicrobial agents, RU 28965, RU 29065 and RU 29702 and comparisons with other orally administered drugs. Antimicrob Agents Chemother 1983; 24: 209–215
- Barlam T, Neu HC. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria. Antimicrob Agents Chemother 1984; 25: 529–531
- Muraoka H, Tsuji A, Ogawa M, Goto S. In vitro and in vivo antibacterial activity of roxithromycin against gram-positive pathogens. Lecture held at International Congress, Roxithromycin: a new antibiotic. Paris May 29–30, 1987
- Wise R, Kirkpatrick B, Ashby J, Andrews JM. Pharmacokinetics and tissue penetration of roxithromycin after multiple dosing. Antimicrob Agents Chemother 1987; 31: 1051–1053
- Puri SK, Lassman HB, Ho I, Sabo R, Barry A. Safety, tolerance and pharmacokinetics of single and multiple oral doses of RU 28965 (a new macrolide antibiotic) in healthy men. Macrolides: a review with an outlook on future developments (14th International Congress of Chemotherapy, Kyoto, 1985), JP Butzler. Excerpta Medica, Geneva 1986; 128–137
- Chastre J, Brun P, Fourtillan JB, Soler P, Basset G, Manuel Ch, Trouillet JL, Gibert C. Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic. Antimicrob Agents Chemother 1987; 31: 1312–1316
- Issell BF, Muggia FM, Carter SK. Etoposide (VP16), Current status and new developments. Academic Press, Orlando, FA 1984
- Gerber AU, Brugger HP, Feller C, Stritzko T, Stalder B. Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: Comparison of murine and human pharmacokinetics. J Infect Dis 1986; 153: 90–97
- Sluiter W, Elzenga-Claasen I, van Hemsbergen-Oomens L WM, van der Voort van der Kley-van Andel A, van Dissel JT, van Furth R. Regulation of granulocyte responses in the blood and peritoneal cavity of CBA and B10 mice during an acute inflammation. J Leukocyte Biol 1987; 42: 653–658
- Kunst MW, Mattie H. Cefazolin and cephradine: relationship between antibacterial activity in vitro and in mice experimentally infected with Escherichia coli. J Infect Dis 1978; 137: 391–402
- Mattie H, Goslings W RO, Noach EL. Cloxacillin and nafcillin: Serum binding and its relationship to antibacterial effects in mice. J Infect Dis 1973; 128: 170–177
- Mattie H, van der Voet GB. The relative potency of amoxycillin and ampicillin in vitro and in vivo. Scand J Infect Dis 1981; 13: 291–296
- Armitage P. Statistical methods in medical research. Blackwell Scientific Publications, London 1971
- Hoogeterp JJ, Mattie H, Krul AM, van Furth R. The quantitative effect of granulocytes on antibiotic treatment of an experimental staphylococcal infection. Antimicrob Agents Chemother 1987; 31: 930–934
- van Waarde D, Hulsing-Hesselink E, Sandkuyl LA, van Furth R. Humoral regulation of monocytopoiesis during the early phase of an inflammatory reaction caused by particulate substances. Blood 1977; 50: 141–154